Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
Highlights in ER-positive breast cancer from SABCS 2025 include key metastatic and early-stage trial results from AMBRE, ...
“Our goal is clear: to transform the cancer experience from fragmented and burdensome to equitable, connected, and ...
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...
Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...